iShares Healthcare Innovation UCITS ETF

PhysicalIndex replication
AccumulatingDistribution policy
0.40 %TER
£1.20B Fund size
195Number of positions
— TD
20.74 %Top 10 share
USDCurrency
4SRI

Current price

£8.22
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

Objectives and Investment Policy The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the STOXX Global Breakthrough Healthcare Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index. The Index reflects the performance of a subset of global equity securities within the STOXX Global Total Market Index (“Parent Index”) which derive significant revenues from healthcare innovation. Companies included in the Index must generate at least 50% (45% for existing companies included in the Index) of their annual revenues from sectors associated with the healthcare innovation theme, such as generic drugs, immunotherapy (e.g. stem cell treatment) and healthcare IT. In addition, the Index aims to have a minimum number of 80 constituents at each Index rebalance however if the application of the revenue filter results in there being fewer than 80 constituents in the Index, it is progressively lowered in accordance with the index provider’s methodology, until the number of constituents is equal to or greater than 80. Companies in the Index must also meet the index provider’s criteria for market capitalization and trading volume and be domiciled in an eligible country which is also determined by the index provider. The Index excludes companies from the Parent Index which are identified by the index provider as being involved in certain business lines/activities, as outlined in the Index description of the Fund in the Fund’s Prospectus. The Fund’s investment in securities that make up the Index will, at the time of purchase, comply with the credit or ESG requirements of the Index. Where securities no longer meet such requirements, the Fund may continue to hold them until they cease to form part of the Index and it is practicable to sell them. The Fund will take into account such ESG criteria only when selecting the securities to be held directly by the Fund. The Fund may obtain indirect exposure (for example, through financial derivative instruments (“FDIs”) (i.e. investments the prices of which are based on one or more underlying assets) and units in collective investment schemes) to securities considered not to satisfy these ESG criteria. The Index may include small, mid and/or large capitalisation constituents of the Parent Index from both developed and emerging market countries globally. Each constituent of the Index is adjusted equally weighted at each Index rebalance. The Fund uses optimising techniques to achieve a similar return to its Index. These techniques may include the strategic selection of certain securities that make up the Index or other securities which provide similar performance to certain constituent securities. These may also include the use of FDIs, which may be used for direct investment purposes. The use of FDIs is expected to be limited for this Share Class. Recommendation: This Fund is suitable for medium to long term investment, though the Fund may also be suitable for shorter term exposure to the Index. Your shares will be accumulating shares (i.e. income will be included in their value). Your shares will be denominated in US Dollar, the Fund's base currency. The shares are listed on one or more stock exchanges and may be traded in currencies other than their base currency. The performance of your shares may be affected by this currency difference. In normal circumstances, only authorised participants (e.g. select financial institutions) may deal in shares (or interests in shares) directly with the Fund. Other investors can deal in shares (or interests in shares) daily through an intermediary on stock exchange (s) on which the shares are traded. For more information on the Fund, Share Class, risks and charges, please see the Fund's prospectus, available on the product pages at www.blackrock.com

Return

Here you can see the performance (incl. distributions) of the iShares Healthcare Innovation UCITS ETF.

Period Perfor­mance
1 Week-3.39 %
1 Month+1.17 %
3 Months+2.76 %
6 Months+28.79 %
1 Year+23.22 %
3 Years+54.10 %(15.51 % p.a.)
5 Years+12.43 %(2.37 % p.a.)
10 Years+117.12 %(8.06 % p.a.)
Since inception +116.70 %(7.88 % p.a.)
Year Perfor­mance
YTD+22.59 %
2025+4.52 %
2024+8.20 %
2023-1.38 %
2022-18.63 %
2021+1.10 %
As of: 19 Nov 2026. Performance displayed in GBP

Master data

Key master data for the iShares Healthcare Innovation UCITS ETF

Total expense ratio (TER) 0.40 %
Index replication Physical
Replication method Optimized
Distribution policy Accumulating
Fund size £1.20B
Fund launch 8 Sept 2016
Fund currency USD
Currency hedging No 
Fund domicileIrland
Risk indicator (SRI)
4 · medium risk class

Risk metrics

Key risk and analysis metrics for the iShares Healthcare Innovation UCITS ETF

Volatility
16.14 % 1 Year
15.40 % 3 Years
17.02 % 5 Years
max. Drawdown
-8.00 % 1 Year
-8.95 % 3 Years
-38.99 % 5 Years
Sharpe Ratio
1.61 1 Year
1.13 3 Years
0.01 5 Years
XLM
16.04

Information about the STOXX Global Breakthrough Healthcare Index

Index name STOXX Global Breakthrough Healthcare (1)
Included securities 241
Stock positions 195
Bond positions 0
Cash and other positions 46

More ETFs tracking the STOXX Global Breakthrough Healthcare Index

Here you can find alternative index funds for the STOXX Global Breakthrough Healthcare.

Fund nameWKNTER
No results

Frequently asked questions

Here you will find all answers to your questions about the iShares Healthcare Innovation UCITS ETF

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.